Success and failure of additional immune modulators in steroid-refractory/resistant pneumonitis related to immune checkpoint blockade

BACKGROUND: Pneumonitis related to immune checkpoint blockade is uncommon but can be severe, fatal or chronic. Steroids are first-line treatment, however, some patients are refractory or become resistant to steroids. Like many immune-related adverse events, little is known regarding the outcomes and...

Descripción completa

Detalles Bibliográficos
Autores principales: Beattie, Jason, Rizvi, Hira, Fuentes, Paige, Luo, Jia, Schoenfeld, Adam, Lin, I-Hsin, Postow, Michael, Callahan, Margaret, Voss, Martin H, Shah, Neil J, Betof Warner, Allison, Chawla, Mohit, Hellmann, Matthew D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878154/
https://www.ncbi.nlm.nih.gov/pubmed/33568350
http://dx.doi.org/10.1136/jitc-2020-001884

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878154/
https://www.ncbi.nlm.nih.gov/pubmed/33568350
http://dx.doi.org/10.1136/jitc-2020-001884

Ejemplares similares